Knowledge base · October 1, 2026 · Stefan Bensmo

Who Actually Manufactures the Nicotine in a Tobacco-Free Pouch?

"Tobacco-free" on a package says nothing about where the nicotine actually comes from. Most tobacco-free pouches contain nicotine purified from tobacco leaf, not synthetically manufactured nicotine — and both paths run, in practice, through a handful of specialized manufacturers globally.

New topic: Nixodine in STRYK is not synthetic nicotine but 6-methylnicotine, a different molecule. Read our separate evidence review of Nixodine, STRYK and nicotine analogues.

Two entirely different origins under the same label

"Tobacco-free" nicotine pouch means the pouch material contains no tobacco leaf — but the nicotine molecule itself can still originate from tobacco. Purified, tobacco-derived nicotine is extracted from tobacco leaf and refined to high purity, while synthetic nicotine (often called "tobacco-free nicotine" or TFN) is manufactured entirely in a chemical lab without any tobacco plant ever being involved. The difference is effectively invisible to the consumer and often unclear even to brand buyers purchasing finished pouch material from a contract manufacturer.

A narrow supply chain

According to trade media covering the tobacco and nicotine sector, the market for purified and synthetic nicotine is dominated by a handful of specialized producers: Contraf-Nicotex-Tobacco (CNT) in Heilbronn, Germany, which produces over 500 metric tons of tobacco-derived nicotine annually with capacity to also manufacture synthetic; Next Generation Labs (NGL) in San Diego, US, described as an early leading player in synthetic nicotine under the TFN and Pharmanic brands; and Tobacco Technology Inc./eLiquiTech in Eldersburg, Maryland, the sole global distributor of its SyNic brand. It's a market with few players rather than an open commodity flow with many suppliers to choose from.

Our read The information on these three companies comes from a trade article with no clear publication date, and the nicotine feedstock market is generally opaque — few companies in the chain communicate openly about their volumes or customers. We flag this list as directional rather than a complete or currently verified map of every supplier active today.

Why the law distinguishes the source — but not the requirement

Until 2022 there was a loophole: because US law defined tobacco products by tobacco origin, synthetic nicotine fell outside the FDA's jurisdiction. That was closed by an amendment to Section 201(rr) of the Food, Drug and Cosmetic Act, passed as part of an omnibus spending bill signed March 15, 2022 and effective April 14 that year. From that date, the US definition of a tobacco product explicitly covers "nicotine from any source," which forced synthetic nicotine manufacturers to seek PMTA authorization on short notice — the application deadline was set at May 14, 2022, with a brief transition period until July 13 that year for products already on the market.

What it means for you

• Ask your contract manufacturer specifically where the nicotine comes from — purified tobacco-derived or fully synthetic — and from whom. "Tobacco-free" on the label doesn't answer that question.
• Account for concentration risk. With only a handful of real producers globally, a single supplier's production disruption or regulatory problem is a real vulnerability across your entire product chain.
• The regulation doesn't care about origin, only that it's nicotine. Since 2022 the US requires the same PMTA process regardless of whether the nicotine is tobacco-derived or synthetic — plan your compliance work accordingly.

We help map the supply chain behind a product ahead of an investment or acquisition — see product development.